MCP-1 is upregulated in COPD patients (Bracke et al., 2007) and induces mucin production and lung inflammation (de Boer et al., 2000; Monzon et al., 2011) characterized by the influx of macrophages (Hautamaki et al., 1997). Here, CCL2 is linked to chronic obstructive pulmonary disease.